Insight Molecular Diagnostics Inc
(IMDX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,247 | -3,864 | -15,754 | -11,255 | -8,284 |
| Depreciation Amortization | 234 | 131 | 1,279 | 1,134 | 997 |
| Accounts payable and accrued liabilities | 767 | -468 | 1,002 | -39 | 1 |
| Other Working Capital | -1,869 | -3,519 | 993 | -104 | -212 |
| Other Operating Activity | 557 | 1,002 | 831 | 1,071 | 788 |
| Operating Cash Flow | $-9,558 | $-6,718 | $-11,649 | $-9,193 | $-6,710 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -18 | -7 | -31 | -31 | -22 |
| Other Investing Activity | 54 | 54 | 0 | 0 | 0 |
| Investing Cash Flow | $36 | $47 | $-31 | $-31 | $-22 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -627 | -334 | -1,181 | -850 | -565 |
| Common Stock Issued | 37,941 | 41,193 | 13,650 | 13,650 | 9,991 |
| Other Financing Activity | 0 | -2,965 | -355 | -355 | 0 |
| Financing Cash Flow | $37,314 | $37,894 | $12,114 | $12,445 | $9,426 |
| Beginning Cash Position | 8,034 | 8,034 | 7,600 | 7,600 | 7,600 |
| End Cash Position | 35,826 | 39,257 | 8,034 | 10,821 | 10,294 |
| Net Cash Flow | $27,792 | $31,223 | $434 | $3,221 | $2,694 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,558 | -6,718 | -11,649 | -9,193 | -6,710 |
| Capital Expenditure | -18 | -7 | -31 | -31 | -22 |
| Free Cash Flow | -9,576 | -6,725 | -11,680 | -9,224 | -6,732 |